The global healthcare reimbursement market size is expected to reach USD 13,315.0 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 5.4% from 2025 to 2030. Supportive government initiatives along with rising cost of prescription medicines are likely to work in favor of the market.
The U.S. Affordable Care Act focuses on controlling and minimizing costs of healthcare. The law supports innovative methods to deliver medical care to reduce healthcare costs and makes affordable health insurance available to more people. Since the Obamacare came into effect in 2014, the number of uninsured children under the age of 18 in the U.S. reduced to 5.0% in 2015 as compared to 9% in 2008.
In addition, the Centre for Medicare & Medicaid Services is working towards delivery of reliable high-quality care, endorsement of efficient results in healthcare system, and making health insurance affordable for millions of Americans who are seeking and getting coverage. The Medicaid spending in the U.S. grew by 3.9% in 2016 or 17.0% of the total National Health Expenditure. And Medicare spending grew by 3.6% in 2016 or 20.0% of the total National Health Expenditure.
The underpaid segment is anticipated to dominate the market through 2026 owing to growing cases of frauds against government healthcare programs and increasing use of healthcare services that are not medically required. There have been several cases where businesses and individuals have defrauded federal and state government healthcare programs by submitting false claims for healthcare services, treatment, pharmaceutical, and medical devices that were never rendered.
Also, the rivalry among healthcare providers and rising pressure from commercial and public payers to reduce costs as well as to improve care are shifting their focus towards value-based care models from volume-based healthcare models.
Request a free sample copy or view report summary: Healthcare Reimbursement Market Report
The underpaid segment dominated the market with a revenue share of 81.2% in 2024. Underpaid claims often result from billing and filing errors, contract discrepancies, insurance processing or calculating errors, and more.
The public payers dominated the global market for healthcare reimbursements in 2024. This is attributed to rooted trust regarding full payments by public payers in multiple countries, especially in nations with mid or low-income levels, history of full payments, government’s involvement in multiple public insurance businesses and more.
The physician office segment held the largest revenue share of 47.4% in 2024. This is attributed to increased hospital admissions due to the growing prevalence of chronic diseases, enhanced hospital infrastructures in multiple countries with growing economies, a rising number of specialty hospitals, and more.
North America dominated the global market of healthcare reimbursement and accounted for a revenue share of 45.7% in 2024.
Grand View Research has segmented the global healthcare reimbursement market on the basis of claim, payer, service provider, and region:
Healthcare Reimbursement Claim Outlook (Revenue, USD Billion, 2018 - 2030)
Underpaid
Full Paid
Healthcare Reimbursement Payer Outlook (Revenue, USD Billion, 2018 - 2030)
Private Payers
Public Payers
Healthcare Reimbursement Service Provider Outlook (Revenue, USD Billion, 2018 - 2030)
Hospitals
Physician Office
Diagnostic Laboratories
Other Service Providers
Healthcare Reimbursement Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Healthcare Reimbursement Market
United HealthCare Services, Inc.
Allianz Care
CVS Health
Reliance Nippon Life Insurance Company Limited
Cigna Healthcare
Aviva
BNPP Paribas Cardif
Wellcare Health Plans, Inc.
Agile Health
Blue Cross Blue Shield Association
"The quality of research they have done for us has been excellent..."